[加速慢性淋巴细胞白血病患者的临床和分子生物学特征]
Z Y Zhou1, L M J Dai1, Y Q Sha1
1Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China.
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
|January 7, 2024
概括
加速慢性淋巴细胞白血病 (aCLL) 呈现出具有攻击性的临床过程,具有共同的不良预后因素. 怀疑病例的早期活检,特别是体积大或高PET-CTSUVmax的病例,对于诊断至关重要.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
更多相关视频
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
21.2K
11:29HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
11.1K
